Search Browse Earnings

MARAVAI LIFESCIENCES HOLDINGS, INC.

Nasdaq:MRVI

Pharmaceutical Preparations·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Brust Bernd

Revenue

$288.9M

-67.3% YoY

FY 2025

Adj. EBITDA

-$18.8M

-6.5% margin

FY 2025

Net Income

-$119.0M

-41.2% margin

FY 2025

EPS (Diluted)

-$0.90

FY 2025

Stock Price

$3.08

-6.4%

2026-03-13

52W Range

$1.67 – $4.11

P/E Ratio

-3.4x

Market Cap

—

Cash

$322.4M

FY 2025

Total Debt

$290.5M

FY 2025

Net Cash

$31.9M

FY 2025

Enterprise Value

—

Debt / EBITDA

1.7x

FY 2025

EV / EBITDA

—

Employees

—